跳至主要内容
临床试验/NCT06827405
NCT06827405已完成不适用

Comparison of the Effectiveness of Oral Lactase Enzyme and Lactose Free Formula in the Management of Secondary Lactose Intolerance in Persistent and Severe Persistent Diarrhea

Muhammad Aamir Latif1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2022年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
Lessening in bloating

研究概览

简要总结

This study aimed to fill the gaps by comparing the effectiveness of oral lactase enzyme and lactose free formula in the management of secondary lactose intolerance in persistent and severe persistent diarrhea.

详细描述

Although it is well understood that oral lactase enzyme can play a pivotal role in hastening recovery due to secondary lactose intolerance in persistent diarrhea, there is limited local data available in this regard. If exogenous oral lactase enzyme is found to be more effective, it would help children receive uninterrupted milk and milk-based diet during the diarrheal episode, as the former would aid digestion and absorption of lactose, thus providing the necessary nutrients especially (calcium) and vitamins so vital in this period of rapid growth.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
6 Months 至 24 Months(Child)
性别
All
接受健康志愿者
否

入选标准

  • •Both genders
  • •Aged 6-24 months
  • •Presented with persistent or severe persistent diarrhea due to secondary lactose intolerance
  • •Patients on formula or mixed feeding, or formula/cow/buffalo milk

排除标准

  • •Severe acute malnutrition
  • •Hemodynamic instability (shock)
  • •Those on oral antibiotics or on excessive juices
  • •With conditions of malabsorptive states (celiac disease, protein losing enteropathy, or irritable bowel syndrome)

研究组 & 干预措施

Lactase enzyme group

Experimental

In this group, 5 drops of lactase enzyme (200 units lactase/drop)/ounce of milk, was added 5-30 minutes before feeding.

干预措施: Lactase enzyme (Dietary Supplement)

Lactose-free formula feed group

Experimental

In this group, lactose-free formula milk/diet was advised.

干预措施: Lactose-free formula feed (Dietary Supplement)

结局指标

主要结局

Lessening in bloating

时间窗: 5 days

It was assessed on the basis of a decrease in the abdominal girth (≤ 1) at the umbilicus by a non- stretchable measuring tape

Resolution of nausea/vomiting no perianal rash or only

时间窗: 5 days

Decrease in the frequency of nausea/vomiting

Resolution of perianal rash

时间窗: 5 days

If no perianal rash or only erythema is seen

Resolution of diarrhea

时间窗: 5 days

It was labeled on the basis of frequency of stools ≤ 4 and consistency of stools ≤ 5 (Bristol Stool Chart, ideal range 3-5)

Reduction in abdominal pain

时间窗: 5 days

A score of ≤ 4, assessed on the basis of faces pain score revised chart (FPS-R), was considered as reduction in pain (a higher score indicating more severe pain)

次要结局

  • Treatment successful(6 days)

研究者

发起方
Muhammad Aamir Latif
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Muhammad Aamir Latif

Research Consultant

RESnTEC, Institute of Research

研究点 (1)

Loading locations...

相似试验